Wellington Management Group
DNTH icon

Wellington Management Group’s Dianthus Therapeutics DNTH Stock Holding History

Wellington Management Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218M Buy
2,595,783
+92,593
+4% +$5.36M 0.04% 363
2025
Q4 		$103M Sell
2,503,190
-74,472
-3% -$2.89M 0.02% 543
2025
Q3 		$101M Buy
2,577,662
+2,503,311
+3,367% +$64M 0.02% 552
2025
Q2 		$1.39M Buy
74,351
+6,369
+9% +$119K ﹤0.01% 1662
2025
Q1 		$1.23M Buy
67,982
+7,645
+13% +$168K ﹤0.01% 1660
2024
Q4 		$1.32M Buy
60,337
+6,552
+12% +$168K ﹤0.01% 1668
2024
Q3 		$1.47M Buy
+53,785
New +$1.5M ﹤0.01% 1632
2022
Q4 		– Sell
-80,389
Closed -$1.81M – 2021
2022
Q3 		$1.81M Sell
80,389
-571
-0.7% -$15.6K ﹤0.01% 1545
2022
Q2 		$1.55M Sell
80,960
-616
-0.8% -$15.2K ﹤0.01% 1591
2022
Q1 		$3.79M Buy
+81,576
New +$4.46M ﹤0.01% 1456

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group's DNTH Position: Q1 2026 in Review

Wellington Management Group increased its Dianthus Therapeutics (DNTH) stake by 3.7% in Q1 2026, buying an estimated $5.36M and bringing the position to 2,595,783 shares worth $218M. The position accounts for 0.04% of the portfolio, ranked #363.

Wellington Management Group first reported a position in DNTH in Q1 2022 and has held it in 10 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Wellington Management Group held 2,595,783 shares of Dianthus Therapeutics worth $218M as of Q1 2026.
  • Wellington Management Group bought 92,593 Dianthus Therapeutics shares in Q1 2026, an estimated $5.36M.
  • Dianthus Therapeutics made up 0.04% of Wellington Management Group's portfolio in Q1 2026, its #363 holding.
  • Wellington Management Group first reported a position in Dianthus Therapeutics in Q1 2022 and has held it in 10 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.